Published in J Rheumatol on June 01, 2000
Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World J Gastroenterol (2014) 1.51
Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol (2014) 0.97
Cure of alopecia areata after eradication of Helicobacter pylori: a new association? World J Gastroenterol (2011) 0.86
Role of Helicobacter pylori infection in autoimmune diseases. Curr Opin Rheumatol (2012) 0.86
Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis? Rheumatol Int (2012) 0.83
Helicobacter pylori and skin autoimmune diseases. World J Gastroenterol (2014) 0.81
Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis. Front Microbiol (2015) 0.81
Environmental risk factors of systemic sclerosis. Semin Immunopathol (2015) 0.80
Role of Helicobacter pylori infection in autoimmune systemic rheumatic diseases. World J Gastroenterol (2014) 0.77
Helicobacter pylori infection in rheumatoid arthritis. J Rheumatol (2001) 0.77
Helicobacter pylori-Mediated Protection against Extra-Gastric Immune and Inflammatory Disorders: The Evidence and Controversies. Diseases (2015) 0.75
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis (2010) 6.75
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92
Systematic review: Sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther (2014) 2.81
Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation (1998) 2.75
Aneurysmal bone cyst of the mobile spine: report on 41 cases. Spine (Phila Pa 1976) (2001) 2.37
Complications of double balloon enteroscopy: a multicenter survey. Endoscopy (2007) 2.28
Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil (2004) 2.28
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease. Inflamm Bowel Dis (2010) 2.17
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet (1998) 2.15
Osteoid osteoma. Direct visual identification and intralesional excision of the nidus with minimal removal of bone. J Bone Joint Surg Br (1999) 2.13
Atrophic gastritis as a cause of hyperhomocysteinaemia. Aliment Pharmacol Ther (2004) 2.09
PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis. Neurogastroenterol Motil (2012) 1.80
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.78
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther (2006) 1.76
Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther (2002) 1.73
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis (2013) 1.67
Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci (1998) 1.61
Caudal blockade as alternative therapeutic approach in neonatal arterial thrombosis. Eur J Pediatr (2001) 1.61
Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases. Am J Gastroenterol (2004) 1.59
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. Aliment Pharmacol Ther (2003) 1.59
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut (2003) 1.56
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.54
Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases. Aliment Pharmacol Ther (2009) 1.54
Push-and-pull enteroscopy in the small bowel using the double-balloon technique: results of a prospective European multicenter study. Endoscopy (2005) 1.53
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein. Clin Rheumatol (2012) 1.52
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther (2001) 1.52
Clinical trial: renzapride treatment of women with irritable bowel syndrome and constipation - a double-blind, randomized, placebo-controlled, study. Aliment Pharmacol Ther (2010) 1.51
Cirrhotic cardiomyopathy. Dig Liver Dis (2007) 1.49
Clinical experience with a new endoscopic over-the-scope clip system for use in the GI tract. Dig Liver Dis (2008) 1.45
Minimally invasive percutaneous fixation in the treatment of thoracic and lumbar spine fractures. Eur Spine J (2009) 1.45
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis (2010) 1.45
Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil (2004) 1.40
Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis (2005) 1.39
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. Dig Liver Dis (2007) 1.36
Clinical features, diagnostic and therapeutic approaches to haematogenous vertebral osteomyelitis. Eur Rev Med Pharmacol Sci (2005) 1.29
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection. Aliment Pharmacol Ther (2000) 1.24
Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol (2001) 1.19
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther (2005) 1.19
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther (2002) 1.19
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther (2007) 1.18
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2007) 1.17
Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol (1997) 1.16
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther (2000) 1.16
Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand (1998) 1.16
Fatty liver and drugs. Eur Rev Med Pharmacol Sci (2005) 1.15
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther (2015) 1.15
Modular endoprosthetic replacement after total resection of the femur for malignant tumour. Int Orthop (1994) 1.14
High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection. Aliment Pharmacol Ther (2004) 1.14
Intraepiphyseal resection of the proximal tibia and its impact on lower limb growth. Clin Orthop Relat Res (1999) 1.13
Helicobacter pylori infection and diabetes. Minerva Med (2010) 1.11
Symptomatic vertebral hemangioma: the treatment of 23 cases and a review of the literature. Chir Organi Mov (2002) 1.11
Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study. Aliment Pharmacol Ther (2013) 1.09
Commentary: Adjunct antibiotic combination therapy for ulcerative colitis--is it time to investigate Fusobacterium varium? Aliment Pharmacol Ther (2014) 1.08
Osteosarcoma of the bones of the foot--an easily misdiagnosed malignant tumor. Mayo Clin Proc (1998) 1.08
Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome. Aliment Pharmacol Ther (2013) 1.07
Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans. Neurogastroenterol Motil (2004) 1.07
Letter: Faecal microbiota transplantation--not a one-size-fits-all approach. Aliment Pharmacol Ther (2014) 1.07
Commentary: antibodies reacting with the infliximab Fab portion--something new? Aliment Pharmacol Ther (2013) 1.07
Staging and treatment of osteoblastoma in the mobile spine: a review of 51 cases. Eur Spine J (2012) 1.07
The Italian experience on paediatric liver transplantation: 1988-1999 report. Dig Liver Dis (2002) 1.06
Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis. Gut (1998) 1.06
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease. Clin Exp Immunol (2013) 1.06
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther (2004) 1.04
Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis. Gut (2004) 1.04
Retracted Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2003) 1.03
Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. Eur Rev Med Pharmacol Sci (2009) 1.03
Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2005) 1.02
The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. Neurogastroenterol Motil (2007) 1.01
Antibody responses and epitope specificities to the Taenia solium cysticercosis vaccines TSOL18 and TSOL45-1A. Parasite Immunol (2006) 1.01
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication. Dig Liver Dis (2008) 1.01
Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. Aliment Pharmacol Ther (2005) 1.01
Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of coeliac disease. Lancet (2000) 1.00
High prevalence of celiac disease in psoriasis. Am J Gastroenterol (2003) 1.00
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease. Am J Gastroenterol (2001) 0.99
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion (2001) 0.99
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus. Autoimmunity (2003) 0.99
Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality "trait" or a reactive illness? Hepatogastroenterology (1997) 0.99
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure. Dig Liver Dis (2007) 0.98
Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther (2012) 0.98
A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. Dig Liver Dis (2004) 0.98
Diagnostic and therapeutic impact of double-balloon enteroscopy (DBE) in a series of 100 patients with suspected small bowel diseases. Dig Liver Dis (2007) 0.98
Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer. Eur Rev Med Pharmacol Sci (2009) 0.98